How Have Morgan Stanley (MS) Insiders Been Trading?


Morgan Stanley (NYSE:MS) finished Thursday with a subtraction of -$1.59 to close at $84.77, a downside of -1.84 percent. An average of 10,635,420 shares of common stock have been traded in the last five days. There was a fall of -$3.49 in the past week, and it reached a new high 9 times over the past 12 months. The last 20 days have seen an average of 8,763,305 shares traded, while the 50-day average volume stands at 7,897,666.

MS stock has decreased by -4.00% in the last month. The company shares reached their 1-month lowest point of $83.16 on 09/06/22. With the stock rallying to its 52-week high on 02/10/22, shares of the company touched a low of $72.05 and a high of $109.73 in 52 weeks. It has reached a new high 9 times so far this year and lost -13.64% or -$13.39 in price. In spite of this, the price is down -22.75% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Insider Transactions

227 days have passed since Morgan Stanley (MS) last reported insider trading activity. SAPERSTEIN ANDREW M, who is Co-President/Head of WM, most recently acquired $17,162 shares at $105.70 per share on Feb 08. In this transaction, the insider spent $1,813,998. Chief Risk Officer, Hotsuki Keishi, disposed of 24,500 shares at a price of $105.00 on Feb 07. The insider now owns more than $2,572,500 worth of shares. Prior to that, Head of Investment Management SIMKOWITZ DANIEL A went on to Sale 18,414 shares at $102.56 each on Jan 31. An amount of $1,888,525 was transacted.

Valuation Metrics

Morgan Stanley (MS) has a trailing price-to-earnings (P/E) ratio of 11.46. The stock’s beta is 1.36. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 2.47, the price-to-book (PB) ratio at 1.54, and the price-to-cash flow ratio at 11.71.

The company has a payout ratio of 37.30%. The company’s most recent quarterly dividend payment was $0.7750 a share, representing a up of 10.71% from $0.70 last year. Its latest increase dividend $0.0750 reported on Thursday July 14 2022.

Financial Health

Further, the company has a long term debt to equity ratio of 2.37 and a total debt to equity ratio of 6.96 for the quarter ending June 29. Its gross profit as reported stood at $19.67 billion compared to revenue of $59.76 billion.

Earnings Surprise

For the three-month period that ended June 29, Morgan Stanley had $226.18 billion in total debt. The analyst consensus anticipated Morgan Stanley’s latest quarter earnings to come in at $30.64 per share, but it turned out to be $27.77, a -9.40% surprise. For the quarter, EBITDA amounted to $4.24 billion. At the end of the quarter ending June 29, Morgan Stanley’s stock balance sheet showed total debt was $353.23 billion. Shareholders own equity worth $1.72 billion.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Morgan Stanley (MS) price momentum. RSI 9-day as of the close on 22 September was 37.37%, suggesting the stock is Neutral, with historical volatility in this time frame at 24.09%.

As of today, MS’s price is $86.89 -3.95% or -$3.49 from its 5-day moving average. MS is currently trading -4.32% lower than its 20-day SMA and +5.19% higher than its 100-day SMA. However, the stock’s current price level is +13.06% above the SMA50 and -14.61% below the SMA200.

The stochastic %K and %D were 37.39% and 50.04%, respectively, and the average true range (ATR) was 2.50. With the 14-day stochastic at 20.43% and the average true range at 2.38, the RSI (14) stands at 42.65%. The stock has reached -1.35 on the 9-day MACD Oscillator while the 14-day reading was at -1.28.

Analyst Ratings

Odeon downgraded Morgan Stanley (NYSE: MS) to a a Sell rating in its most recent analyst report. Previously, the stock was rated as a Hold. The consensus rating for Morgan Stanley (MS) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell MS, while 7 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 4 analysts, while 16 others rate it as a “buy”.

What is MS’s price target for the next 12 months?

Analysts predict a range of price targets between $80.00 and $108.00, with a median target of $97.00. Taking a look at these predictions, the average price target given by analysts for Morgan Stanley (MS) stock is $95.81.


Please enter your comment!
Please enter your name here